Vikas Gupta

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Renee Julia Manalo

Emory University

UNITED STATES

View details

Kevin Hall

Winship Cancer Institute of Emory University

UNITED STATES

View details

Roberta Buono

University of California, Irvine

UNITED STATES

View details

Sagar Lonial

UNITED STATES

View details

Benjamin Barwick

Assistant Professor

Emory University

UNITED STATES

View details

Craig Hofmeister

Associate professor

Emory University

UNITED STATES

View details

Ajay K. Nooka

UNITED STATES

View details

Nisha Joseph

Associate Professor

Winship Cancer Institute of Emory University

UNITED STATES

View details

Lawrence Boise

Professor

Emory University

UNITED STATES

View details

Jonathan Keats

Director of Bioinformatics / Assistant Professor

Translational Genomics Research Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vikas Gupta

Research Interests

Explore related searches

Contact this professor

Articles (14)

Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract

Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience

Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Venetoclax ex vivo functional profiling predicts improved progression-free survival.

Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life

Venetoclax sensitivity in multiple myeloma is associated with B cell gene expression.

Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia

Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma

BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma

Natural history of multiple myeloma patients refractory to venetoclax: A single center experience.

Collaborators (10)

Renee Julia Manalo

Kevin Hall

Roberta Buono

Sagar Lonial

Benjamin Barwick

Craig Hofmeister

Ajay K. Nooka

Nisha Joseph

Lawrence Boise

Jonathan Keats

Make your next move.